What VIETSTAR BIOMEDICAL RESEARCH does

VietStar Biomedical Research is a privately held Vietnamese Contract Research Organization (CRO) founded in 2016 in Hanoi, with a 26-person team serving both domestic Vietnamese and top-10 international pharmaceutical and biotechnology sponsors. The firm is approved by the Vietnam Ministry of Health to support study sites and sponsors in clinical trials under MOH regulations and ICH GCP, and offers a 12-service portfolio spanning the full drug development lifecycle from Phase I through Phase IV — including full-service clinical trials, feasibility and site selection, regulatory management, clinical project management, site monitoring, data management and biostatistics, protocol and ICF development, medical document translation, quality assurance, quantitative clinical development (QCD) modeling and simulation, and CRA/CRC resourcing. Its technology layer is anchored in a feasibility engine that combines pharmacy data, prescription records, heat maps, trial result databases and survey tools, and a risk-based clinical monitoring approach built on electronic data capture and remote monitoring. The Technical Director has personally executed over 200 clinical trials since 1996, and over 90% of the clinical team holds medical or pharmaceutical backgrounds.

VietStar operates as a B2B professional-services business, selling contracts directly to pharmaceutical and biotechnology sponsors through an enterprise field-sales motion rather than through any public, self-service, or API-based channel. Pricing is project-based and not publicly disclosed, consistent with custom CRO engagements. The company monetizes across two primary customer segments — top-10 international pharmaceutical companies operating in Vietnam (named logos include AstraZeneca, Novartis, La Roche, and Novo Nordisk) and domestic Vietnamese pharma and life-sciences companies (VinGroup/Vinsmart, Vinmec, Vietlife, Vabiotech) — with academic and public-health sponsors (Oxford University CRU, UNC, FHI 360, Woolcock Institute) as a secondary segment. Geographic footprint is officially single-country (Vietnam), but customer base is international, and service delivery is enabled by a national site network spanning Bach Mai Hospital, K Hospital, Vietnam National University Hospital, Pasteur Institute HCMC, Cho Ray Hospital, and Hue Central Hospital. The company is not currently listed, has no parent or subsidiaries, and has not disclosed any funding rounds, M&A activity, or public financial figures.

Name

VIETSTAR BIOMEDICAL RESEARCH

Legal name

VietStar Biomedical Research

Website

https://vietstar-research.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

VietStar Biomedical Research is a privately held Vietnamese Contract Research Organization that runs Phase I–IV clinical trials and regulatory services for top-10 international pharmaceutical companies, domestic Vietnamese pharma and biotech firms, and academic sponsors, leveraging a 12-service portfolio, risk-based monitoring, and a national hospital site network.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Clinical Trial Site Operations & Study Coordination (HLAGACAE), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH), Clinical Research & Trial Central Laboratories (HLAFAMAL)

Keywords

• Clinical research services
• Contract research organization
• Clinical trial management
• Regulatory affairs services
• Pharmaceutical development

Headquarters

HQ city

Hanoi

HQ country

Vietnam

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. CRO Clinical Research Services: Contract-based professional services providing full-service clinical trial solutions including trial design, project management, site management, data management, statistical analysis, medical monitoring, pharmacovigilance, and medical writing for pharmaceutical and biotechnology product development from phase I through phase IV.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

VietStar Biomedical Research is a Vietnamese Contract Research Organization (CRO) approved by the Vietnam Ministry of Health that delivers full-service clinical trial solutions for pharmaceutical and biotechnology sponsors. The company manages end-to-end clinical research and regulatory services from Phase I through Phase IV, including trial design, feasibility and site selection, project management, clinical monitoring, data management and biostatistics, regulatory submissions, medical writing, pharmacovigilance, and quality assurance.

Product overview

VIETSTAR BIOMEDICAL RESEARCH is a Vietnamese Contract Research Organization (CRO) approved by Vietnam Ministry of Health to support study sites and sponsors in clinical trials in accordance with MOH regulations and ICH GCP. The company offers a comprehensive portfolio of 12 interconnected clinical research services spanning the entire drug development lifecycle from Phase I through Phase IV. Core offerings include Full-service Clinical Trials for registration (the primary service encompassing trial design, project management, site monitoring, data management, and medical writing), paired with specialized services including Clinical Trial feasibility & site selection, Regulatory management, Protocol and Informed Consent Form Development, Clinical site management & Monitoring, Data Management and Analysis, Medical Document Translation Services, Clinical Trial Quality Assurance, Quantitative Clinical Development Services, Insourcing/outsourcing CRA/CRC, Clinical Project management, and Other drug and vaccine related activities. The company serves both domestic and international pharmaceutical companies and operates across multiple therapeutic areas including hypertension, arthritis, oncology, hepatitis, diabetes, infectious diseases, and psoriasis.

Differentiator

Problem solved

Functional benefit

Products and services

• Full-service Clinical Trials for registration
• Insourcing/outsourcing CRA/CRC
• Clinical Trial feasibility & site selection
• Clinical Project management
• Regulatory management
• Protocol and Informed Consent Form Development
• Clinical site management & Monitoring
• Data Management and Analysis
• Medical Document Translation Services
• Clinical Trial Quality Assurance
• Quantitative Clinical Development Services
• Other drug and vaccine related activities

Quantifiable outcome

• Achieved enrollment goals across all projects 98% of the time
• +3 more outcomes

Named customers10 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• Bach Mai HospitalcoreStrategic or Co-development PartnerMajor national partner hospital providing clinical trial site infrastructure for VietStar's CRO operations in Vietnam. VietStar collaborates with the hospital for site selection and clinical trial execution.
• K HospitalcoreStrategic or Co-development PartnerNational oncology specialized hospital partner providing cancer clinical trial sites. VietStar conducts oncology trials at this facility.
• Vietnam National University Hospital (Y Dược TP HCM)coreStrategic or Co-development PartnerMajor teaching hospital in Ho Chi Minh City providing clinical trial infrastructure and patient access for VietStar's CRO services.
• Pasteur Institute Ho Chi Minh CitycoreStrategic or Co-development PartnerNational infectious disease research institute partner for vaccine and infectious disease clinical trials.
• Cho Ray HospitalcoreStrategic or Co-development PartnerMajor tertiary hospital in Ho Chi Minh City providing clinical trial sites for various therapeutic areas.
• Hue Central HospitalcoreStrategic or Co-development PartnerCentral-level hospital in Central Vietnam providing clinical trial infrastructure for VietStar operations in the region.
• Woolcock Institute of Medical ResearchminorStrategic or Co-development PartnerInternational research partner collaborating on clinical trial projects with VietStar.
• Oxford University Clinical Research UnitminorStrategic or Co-development PartnerInternational academic clinical research organization sponsoring clinical trials in Vietnam through VietStar.
• Family Health International (FHI 360)minorStrategic or Co-development PartnerInternational health research organization sponsoring clinical trials in Vietnam through VietStar.

Scale indicators4 records

Recent moves5 records

Expansion highlights6 records

Broad incumbents

• IQVIA: World's largest CRO with established Vietnam presence. Comparable as a full-service clinical CRO serving the same top-10 pharma customers, but at incomparably larger scale with global operations and integrated technology/data assets.
• ICON plc: Global top-5 CRO with strong Asia-Pacific operations including Vietnam. Comparable in service breadth and top-pharma customer base, but vastly larger in scale, with broader geographic reach and broader therapeutic capabilities.
• Parexel International: Global mid-to-large CRO with established Asia-Pacific operations. Comparable as a full-service clinical CRO serving multinational pharma sponsors, though with significantly broader geographic reach and therapeutic capabilities.
• WuXi AppTec: China-based global CRO/CDMO with broad clinical and laboratory services portfolio. Comparable in full-service clinical offerings and customer base, but operates at massive scale with global footprint and integrated drug discovery through clinical capabilities.

Emerging players

• PSI CRO: Mid-size global CRO with strong emerging-market and oncology focus. Comparable in mid-size CRO positioning and full-service clinical offerings, though with broader European and Asian geographic reach versus VietStar's single-country footprint.

Regional players

• Tigermed (Hangzhou Tigermed Consulting): China's largest domestic CRO providing full-service clinical development across Asia. Comparable as a regional full-service CRO serving multinational pharma sponsors, though operating primarily in China and selected APAC markets rather than Vietnam.
• Pharmaron: China-headquartered CRO/CDMO with full-service clinical development offerings across Asia, US, and UK. Comparable in service breadth (clinical + lab services) and customer base, but operates at significantly larger scale and broader geographic footprint.
• CMIC Group: Japan's largest CRO offering full-service clinical trial support across Asia. Comparable as a regional CRO serving Japanese and multinational pharma in Asian markets, though concentrated in Japan rather than Southeast Asia.
• Siro Clinpharm: India-headquartered mid-size CRO with operations across emerging Asia. Comparable as a mid-size emerging-market full-service CRO serving international pharma, with similar scale profile though India-based rather than Vietnam-based.

Direct peers

• Novotech (Novotech Health Holdings): Asia-Pacific-focused mid-size CRO with deep operations across multiple Asian countries including Vietnam. Comparable to VietStar in business model (full-service clinical CRO), target customer base (international pharma sponsors), and regional focus, but at significantly greater scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/VietStarBiomedicalResearch
• LinkedInlinkedin.com/company/vietstar-biomedical-research

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VIETSTAR BIOMEDICAL RESEARCH